Anti-venom Market Share

Statistics for the 2023 & 2024 Anti-venom market share, created by Mordor Intelligence™ Industry Reports. Anti-venom share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Anti-venom Industry

The anti-venom market is competitive, and consists of several market players. Most developing countries with established biotechnological facilities have local scientific expertise, which creates favorable conditions and the atmosphere to establish local anti-venom manufacturing practices. Countries such as Brazil, Costa Rica, Egypt, France, India, Mexico, South Africa, and Thailand have large, well-established anti-venom manufacturers. The major market players operating in the anti-venom market include BTG PLC, Pfizer Inc., Merck KGaA (Sigma Aldrich), Boehringer Ingelheim, and CSL Limited, among others.

Anti-Venom Market Leaders

  1. Pfizer Inc.

  2. Merck KGaA (Sigma Aldrich)

  3. Boehringer Ingelheim

  4. CSL Limited

  5. Bharat Serums and Vaccines Ltd

*Disclaimer: Major Players sorted in no particular order

Anti-venom Market Concentration

Anti Venom Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)